Spartalizumab (anti-PD-1) T35396
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
CAS nr:
Purity:
98%
Molecular Weight:
SMILES:
Formula:
Pathway:
Apoptosis,Immunology/Inflammation,Cell Cycle/Checkpoint
Target:
PD-1/PD-L1,PD-1/PD-L1,PD-1/PD-L1
